SCHEMBL4923403

SCHEMBL4923403

COc1ccc(CNC(=O)c2sc(Nc3ccccc3OC)nc2C)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.66
KDM4E B2RXH2 4/20 0.66
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
ALDH1A1 P00352 2/20 0.66
GSK3A P49840 1/20 0.55
GSK3B P49841 1/20 0.55
SCD O00767 2/20 0.53
LMNA P02545 2/20 0.53
PPARA Q07869 1/20 0.52
NPSR1 Q6W5P4 1/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
PKM P14618 1/20 0.48
HTT P42858 1/20 0.48
NPC1 O15118 1/20 0.48
NFKB1 P19838 1/20 0.48
RAB9A P51151 1/20 0.48
GFER P55789 1/20 0.48
NFKB2 Q00653 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928627 0.95 MAPT (0.65) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL4926481 0.94 ALDH1A1 (0.66) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL4923415 0.94 ALDH1A1 (0.71) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL4916215 0.93 MAPT (0.64) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL14184689 0.92 MAPT (0.66) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL4916217 0.92 MAPT (0.63) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL4925363 0.92 ALDH1A1 (0.58) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL4923591 0.91 MAPT (0.62) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL14184601 0.91 MAPT (0.62) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL14214493 0.91 MAPT (0.62) MAPTKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 MAPT 1729/4885KDM4E 1589/4885MEN1 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.